Dyadic International (DYAI) Amortization of Deferred Charges (2024 - 2026)
Dyadic International (DYAI) posted Amortization of Deferred Charges of $7381.0 for Q1 2026, down 41.39% sequentially from $12593.0 in Q4 2025, and down 37.25% YoY from $11762.0 in Q1 2025.
Dyadic International (DYAI) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends
Dyadic International has reported Amortization of Deferred Charges for 3 years, with the latest figure at $7381.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges fell 37.25% year-over-year to $7381.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44316.0 (down 38.16% YoY) and the FY2025 annual result came in at $48697.0, down 22.73% from the prior year.
- Amortization of Deferred Charges eased to $7381.0 in Q1 2026 per DYAI's latest filing, from $12593.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $23591.0 in Q2 2024 and troughed at $3125.0 in Q1 2024.
- A 3-year average of $13233.1 and a median of $12310.0 in 2025 frame the typical range for Amortization of Deferred Charges.
- The widest YoY moves for Amortization of Deferred Charges: up 276.38% in 2025, down 49.0% in 2025.
- Over 3 years, Amortization of Deferred Charges stood at $19060.0 in 2024, then tumbled by 33.93% to $12593.0 in 2025, then tumbled by 41.39% to $7381.0 in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $7381.0, $12593.0, and $12310.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,381.00 |
| Mar 31, 2026 | 7,381.00 |
| Dec 31, 2025 | 12,593.00 |
| Dec 31, 2025 | 12,593.00 |
| Sep 30, 2025 | 12,310.00 |
| Sep 30, 2025 | 12,310.00 |
| Jun 30, 2025 | 12,032.00 |
| Jun 30, 2025 | 12,032.00 |
| Mar 31, 2025 | 11,762.00 |
| Mar 31, 2025 | 11,762.00 |
| Dec 31, 2024 | 19,060.00 |
| Dec 31, 2024 | 19,060.00 |
| Sep 30, 2024 | 17,244.00 |
| Sep 30, 2024 | 17,244.00 |
| Jun 30, 2024 | 23,591.00 |
| Jun 30, 2024 | 23,591.00 |
| Mar 31, 2024 | 3,125.00 |
| Mar 31, 2024 | 3,125.00 |